Altre lingue Nahdi Medical Company

Azioni

4164

SA15HG521213

Prezzo di chiusura Saudi Arabian S.E. Altri mercati azionari 00:00:00 30/04/2024			Variaz. 5gg	Var. 1 gen.
138,2 ^SAR	+1,62%		-1,29%	+0,88%

18/03	Nahdi Medical Company riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
2023	Nahdi Medical Company riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Nahdi Medical Company Reports Earnings Results for the Full Year Ended December 31, 2023	18/03
Nahdi Medical Posts Higher FY23 Net Profit, Revenue	18/03
Nahdi Medical Company Approves Cash Dividend Distribution for the Second Half of 2023	17/03
Nahdi Medical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11
OptiBiotix says market still "volatile" but partner sales improving	01/11
Saudi Arabia healthcare group Fakeeh Care weighs IPO, appoints HSBC - sources	27/08/23
Nahdi Medical Company Reports Earnings Results for the Second Quarter Ended June 30, 2023	03/08/23
Nahdi Medical Company Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23
Nahdi Medical Company Reports Earnings Results for the Full Year Ended December 31, 2022	20/03/23
Nahdi Medical Company Reports Earnings Results for the Third Quarter Ended September 30, 2022	06/11/22
Nahdi Medical Company Reports Earnings Results for the Third Quarter Ended September 30, 2022	06/11/22
OptiBiotix Health gets approval to sell products in Saudi Arabia	24/10/22
OptiBiotix Health Plc Announces Exclusive Distributor Nahdi Medical Co Has Received Approval from the Saudi Food and Drug Authority for GoFigure Shakes and Bars Containing Patented Weight Management Aid Slimbiome	24/10/22
Nahdi Medical Company Announces the Establishment of a New Company, Owned by its Subsidiaries	29/09/22
Certain Ordinary Shares of Nahdi Medical Company are subject to a Lock-Up Agreement Ending on 20-SEP-2022.	20/09/22
Nahdi Medical Company(SASE:4164) added to S&P Global BMI Index	19/09/22
Nahdi Medical Company(SASE:4164) added to S&P Pan Arab Composite	19/09/22
Nahdi Medical Company Announces Distribution of Cash Dividend for First Half of 2022, Payable on August 25, 2022	09/08/22
Nahdi Medical Company(SASE:4164) added to FTSE All-World Index	30/03/22
Nahdi Medical Company has completed an IPO in the amount of SAR 5.109 billion.	20/03/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Nahdi Medical Company

Azioni

4164

SA15HG521213

Altre lingue

Filtri